Amplicons on chromosome 3 contain oncogenes induced by recurrent exposure to 12-O-tetradecanoylphorbol-13-acetate and sodium n-butyrate and Epstein-Barr virus reactivation in a nasopharyngeal carcinoma cell line

Cancer Genetics and Cytogenetics

Volumn 185, Issue 1, 2008, Pages 1-10

  Lee, Chia Huei ^a   Fang, Chih Yeu ^a   Jinn Chyuan Sheu, Jim ^b   Chang, Yao ^a   Takada, Kenzo ^c   Chen, Jen Yang ^a,d  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c HOKKAIDO UNIVERSITY   (Japan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; PHORBOL 13 ACETATE 12 MYRISTATE;

AMPLICON; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CHROMOSOME 3; CHROMOSOME ABERRATION; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE EXPRESSION; GENE LOCUS; HUMAN; HUMAN CELL; NASOPHARYNX CARCINOMA; ONCOGENE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ROUNDABOUT AXON GUIDANCE RECEPTOR HOMOLOG 1 GENE; SKIL ONCOGENE; VIRUS REACTIVATION;

BUTYRATES; CARCINOGENS; CARCINOMA; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 3; HERPESVIRUS 4, HUMAN; HUMANS; NASOPHARYNGEAL NEOPLASMS; ONCOGENES; TETRADECANOYLPHORBOL ACETATE; VIRUS ACTIVATION;

HUMAN HERPESVIRUS 4;

EID: 47749124917     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2008.03.014     Document Type: Article

References (39)

1. Rickinson A.B., and Kieff E. Epstein-Barr virus. In: Knipe D.M., Howley P.M., Howley P.M., and Griffin D.E. (Eds). Fields' virology. 4th ed. (2001), Lippincott Williams & Wilkins, Philadelphia 2575-2627
2. Robinson J.E., and Miller G. Biology of lymphoid cells transformed by Epstein-Barr virus. In: Roizman B. (Ed). The herpesviruses (1982), Plenum, New York 151-207
3. Thorley-Lawson D.A., Miyashita E.M., and Khan G. Epstein-Barr virus and the B cell: that's all it takes. Trends Microbiol 4 (1996) 204-208
4. Gao X., Ikuta K., Tajima M., and Sairenji T. 12-O-Tetradecanoylphorbol-13-acetate induces Epstein-Barr virus reactivation via NF-κB and AP-1 as regulated by protein kinase C and mitogen-activated protein kinase. Virology 286 (2001) 91-99
5. Luka J., Kallin B., and Klein G. Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate. Virology 94 (1979) 228-231
6. Kawanishi M., and Ito Y. Effect of short-chain fatty acids on Epstein-Barr virus early and viral capsid antigen induction in P3HR-1 cells. Cancer Lett 11 (1980) 129-132
7. Faggioni A., Zompetta C., Grimaldi S., Barile G., Frati L., and Lazdins J. Calcium modulation activates Epstein-Barr virus genome in latently infected cells. Science 232 (1986) 1554-1556
8. Asai S., Nakamura Y., Yamamura M., Ikezawa H., and Namikawa I. Quantitative analysis of the Epstein-Barr virus-inducing properties of short-chain fatty acids present in the culture fluids of oral bacteria. Arch Virol 119 (1991) 291-296
9. Ito Y., Yanase S., Fujita J., Harayama T., Takashima M., and Imanaka H. A short-term in vitro assay for promoter substances using human lymphoblastoid cells latently infected with Epstein-Barr virus. Cancer Lett 13 (1981) 29-37
10. Chien Y.C., Chen J.Y., Liu M.Y., Yang H.I., Hsu M.M., Chen C., and Yang C.S. Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. N Engl J Med 345 (2001) 1877-1882
11. Old L.J., Boyse E.A., Oettgen H.F., Harven E.D., Geering G., Williamson B., and Clifford P. Precipitating antibody in human serum to an antigen present in cultured Burkitt's lymphoma cells. Proc Natl Acad Sci U S A 56 (1966) 1699-1704
12. Zeng Y. Seroepidemiological studies on nasopharyngeal carcinoma in China. Adv Cancer Res 44 (1985) 121-138
13. de-The G. Epidemiology of Epstein-Barr virus and associated diseases in man. In: Roizman B. (Ed). The herpesviruses (1982), Plenum, New York 25-103
14. Lo Y.M., Chan L.Y., Lo K.W., Leung S.F., Zhang J., Chan A.T., Lee J.C., Hjelm N.M., Johnson P.J., and Huang D.P. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. Cancer Res 59 (1999) 1188-1191
15. Cochet C., Martel-Renoir D., Grunewald V., Bosq J., Cochet G., Schwaab G., Bernaudin J.F., and Joab I. Expression of the Epstein-Barr virus immediate early gene, BZLF1, in nasopharyngeal carcinoma tumor cells. Virology 197 (1993) 358-365
16. Feng P., Ren E.C., Liu D., Chan S.H., and Hu H. Expression of Epstein-Barr virus lytic gene BRLF1 in nasopharyngeal carcinoma: potential use in diagnosis. J Gen Virol 81 (2000) 2417-2423
17. Martel-Renoir D., Grunewald V., Touitou R., Schwaab G., and Joab I. Qualitative analysis of the expression of Epstein-Barr virus lytic genes in nasopharyngeal carcinoma biopsies. J Gen Virol 76 (1995) 1401-1408
18. Zhang J.X., Chen H.L., Zong Y.S., Chan K.H., Nicholls J., Middeldorp J.M., Sham J.S., Griffin B.E., and Ng M.H. Epstein-Barr virus expression within keratinizing nasopharyngeal carcinoma. J Med Virol 55 (1998) 227-233
19. Liu M.Y., Shih Y.Y., Li L.Y., Chou S.P., Sheen T.S., Chen C.L., Yang C.S., and Chen J.Y. Expression of the Epstein-Barr virus BHRF1 gene, a homologue of Bcl-2, in nasopharyngeal carcinoma tissue. J Med Virol 61 (2000) 241-250
20. Cabras G., Decaussin G., Zeng Y., Djennaou D., Melouli H., Broully P., Bouguermouh A.M., and Ooka T. Epstein-Barr virus encoded BALF1 gene is transcribed in Burkitt's lymphoma cell lines and in nasopharyngeal carcinoma's biopsies. J Clin Virol 34 (2005) 26-34
21. Hirayama T., and Ito Y. A new view of the etiology of nasopharyngeal carcinoma. Prev Med 10 (1981) 614-622
22. Hui A.B., Lo K.W., Teo P.M., To K.F., and Huang D.P. Genome wide detection of oncogene amplifications in nasopharyngeal carcinoma by array based comparative genomic hybridization. [Erratum in: Int J Oncol 2002;21:451]. Int J Oncol 20 (2002) 467-473
23. Li X., Wang E., Zhao Y.D., Ren J.Q., Jin P., Yao K.T., and Marincola F.M. Chromosomal imbalances in nasopharyngeal carcinoma: a meta-analysis of comparative genomic hybridization results. J Transl Med 4 (2006) 4-13
24. Or Y.Y., Hui A.B., Tam K.Y., Huang D.P., and Lo K.W. Characterization of chromosome 3q and 12q amplicons in nasopharyngeal carcinoma cell lines. Int J Oncol 26 (2005) 49-56
25. Kwong J., Chow L.S., Wong A.Y., Hung W.K., Chung G.T., To K.F., Chan F.L., Daigo Y., Nakamura Y., Huang D.P., and Lo K.W. Epigenetic inactivation of the deleted in lung and esophageal cancer 1 gene in nasopharyngeal carcinoma. Genes Chromosomes Cancer 46 (2007) 171-180
26. Ying J., Li H., Seng T.J., Langford C., Srivastava G., Tsao S.W., Putti T., Murray P., Chan A.T., and Tao Q. Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation. Oncogene 25 (2006) 1070-1080
27. Yau W.L., Lung H.L., Zabarovsky E.R., Lerman M.I., Sham J.S., Chua D.T., Tsao S.W., Stanbridge E.J., and Lung M.L. Functional studies of the chromosome 3p21.3 candidate tumor suppressor gene BLU/ZMYND10 in nasopharyngeal carcinoma. Int J Cancer 119 (2006) 2821-2826
28. Zhang Z., Sun D., Van do N., Tang A., Hu L., and Huang G. Inactivation of RASSF2A by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma. Int J Cancer 120 (2007) 32-38
29. Chang Y., Tung C.H., Huang Y.T., Lu J., Chen J.Y., and Tsai C.H. Requirement for cell-to-cell contact in Epstein-Barr virus infection of nasopharyngeal carcinoma cells and keratinocytes. J Virol 73 (1999) 8857-8866
30. Lin C.T., Wong C.I., Chan W.Y., Tzung K.W., Ho J.K., Hsu M.M., and Chuang S.M. Establishment and characterization of two nasopharyngeal carcinoma cell lines. Lab Invest 62 (1990) 713-724
31. Tsai C.H., Williams M.V., and Glaser R. Characterization of two monoclonal antibodies to Epstein-Barr virus diffuse early antigen which react to two different epitopes and have different biological function. J Virol Methods 33 (1991) 47-52
32. Pfaffl M.W., Horgan G.W., and Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30 (2002) e36
33. Xian J., Aitchison A., Bobrow L., Corbett G., Pannell R., Rabbitts T., and Rabbitts P. Targeted disruption of the 3p12 gene, Dutt1/Robo1, predisposes mice to lung adenocarcinomas and lymphomas with methylation of the gene promoter. Cancer Res 64 (2004) 6432-6437
34. Gröne J., Doebler O., Loddenkemper C., Hotz B., Buhr H.J., and Bhargava S. Robo1/Robo4: differential expression of angiogenic markers in colorectal cancer. Oncol Rep 15 (2006) 1437-1443
35. Ito H., Funahashi S., Yamauchi N., Shibahara J., Midorikawa Y., Kawai S., Kinoshita Y., Watanabe A., Hippo Y., Ohtomo T., Iwanari H., Nakajima A., Makuuchi M., Fukayama M., Hirata Y., Hamakubo T., Kodama T., Tsuchiya M., and Aburatani H. Identification of ROBO1 as a novel hepatocellular carcinoma antigen and a potential therapeutic and diagnostic target. Clin Cancer Res 12 (2006) 3257-3264
36. Haas K., Kundi M., Sperr W.R., Esterbauer H., Ludwig W.D., Ratei R., Koller E., Gruener H., Sauerland C., Fonatsch C., Valent P., and Wieser R. Expression and prognostic significance of different mRNA 5′-end variants of the oncogene EVI1 in 266 patients with de novo AML: EVI1 and MDS1/EVI1 overexpression both predict short remission duration. Genes Chromosomes Cancer 47 (2008) 288-298
37. Mitani K. Molecular mechanisms of leukemogenesis by AML1/EVI-1. Oncogene 23 (2004) 4263-4269
38. INK4c. Oncogene 23 (2004) 5409-5414
39. Price B.D., and Calderwood S.K. Increased sequence-specific p53-DNA binding activity after DNA damage is attenuated by phorbol esters. Oncogene 8 (1993) 3055-3062